Genetic overlap between idiopathic pulmonary fibrosis and covid-19

HIGHLIGHTS

• who: Richard J. Allen from the Conflict of interest: RJ. Allen is an Action for Pulmonary Fibrosis Mike Bray Research Fellow, and received registration fees for attendance of British Thoracic Society , winter meeting from British Thoracic Society, outside the submitted work. R.G. Jenkins is a trustee of Action for Pulmonary Fibrosis and reports personal fees from AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Chiesi, Daewoong, Galapagos, Galecto, GlaxoSmithKline, Heptares, NuMedii, PatientMPower, Pliant, Promedior, Redx, Resolution Therapeutics, Roche, Veracyte and Vicore. L.V. Wain reports research funding from GSK and Orion, a research collaboration with Genentech and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.